By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Biocept, Inc. 

2151 Las Palmas Drive, Suite C

Carlsbad  California  92009  U.S.A.
Phone: 760-804-9580 Fax: 760-804-6238



Company News
Biocept, Inc. (BIOC) Release: Company Awarded Patent In Australia For The Use Of Antibodies In Microchannels To Capture Circulating Tumor Cells And Other Rare Cells 1/19/2017 7:27:52 AM
Clinical Utility Of Biocept, Inc. (BIOC)'s Liquid Biopsy Platform Demonstrated In Study Results Presented At The 2016 San Antonio Breast Cancer Symposium 12/8/2016 7:21:54 AM
Biocept, Inc. (BIOC) Presents Robust Analytical Validation Study Results For Its PD-L1 Liquid Biopsy Test At The 17th IASLC World Conference On Lung Cancer 12/7/2016 8:40:08 AM
Biocept, Inc. (BIOC) Reports 2016 Third Quarter Financial Results 11/10/2016 4:51:26 PM
Biocept, Inc. (BIOC) To Release Third Quarter Financial Results And Host Investor Conference Call On November 9, 2016 10/31/2016 8:51:50 AM
Biocept, Inc. (BIOC) Appoints David Moskowitz Vice President, Strategy & Corporate Communications 10/27/2016 8:24:18 AM
Study Results Presented At The 2016 ESMO Annual Congress Demonstrate Leading Clinical Performance With Biocept, Inc. (BIOC)'s ctDNA Liquid Biopsy Platform vs. Tissue Biopsy 10/20/2016 10:02:27 AM
Biocept, Inc. (BIOC) Announces Closing Of $10 Million Public Offering Of Common Stock And Warrants 10/20/2016 7:59:26 AM
Biocept, Inc. (BIOC) Announces Pricing Of $10 Million Public Offering Of Common Stock And Warrants 10/14/2016 9:09:27 AM
Clinical Results Demonstrating the Performance Of Biocept, Inc. (BIOC)'s Target Selector Platform To Be Presented At The 2016 European Society Of Medical Oncology Annual Congress 9/29/2016 11:46:40 AM